pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
mianserin viatris 30 mg
viatris limited - mianserinhydroklorid - tablett, filmdrasjert - 30 mg
mianserin viatris 10 mg
viatris limited - mianserinhydroklorid - tablett, filmdrasjert - 10 mg
loperamid viatris 2 mg
viatris limited - loperamidhydroklorid - kapsel, hard - 2 mg
tamsulosin viatris 0.4 mg
viatris limited - tamsulosinhydroklorid - kapsel med modifisert frisetting, hard - 0.4 mg
atenolol viatris 50 mg
viatris limited - atenolol - tablett, filmdrasjert - 50 mg
atenolol viatris 25 mg
viatris limited - atenolol - tablett, filmdrasjert - 25 mg
atenolol viatris 100 mg
viatris limited - atenolol - tablett, filmdrasjert - 100 mg
baklofen viatris 10 mg
viatris limited - baklofen - tablett - 10 mg